163 related articles for article (PubMed ID: 12222675)
1. Processing of the human transferrin receptor at distinct positions within the stalk region by neutrophil elastase and cathepsin G.
Kaup M; Dassler K; Reineke U; Weise C; Tauber R; Fuchs H
Biol Chem; 2002 Jun; 383(6):1011-20. PubMed ID: 12222675
[TBL] [Abstract][Full Text] [Related]
2. Proteolysis of C3 on U937 cell plasma membranes. Purification of cathepsin G.
Maison CM; Villiers CL; Colomb MG
J Immunol; 1991 Aug; 147(3):921-6. PubMed ID: 1861080
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil proteases can inactivate human PAR3 and abolish the co-receptor function of PAR3 on murine platelets.
Cumashi A; Ansuini H; Celli N; De Blasi A; O'Brien PJ; Brass LF; Molino M
Thromb Haemost; 2001 Mar; 85(3):533-8. PubMed ID: 11307827
[TBL] [Abstract][Full Text] [Related]
4. Single residue determines the specificity of neutrophil elastase for Shigella virulence factors.
Averhoff P; Kolbe M; Zychlinsky A; Weinrauch Y
J Mol Biol; 2008 Apr; 377(4):1053-66. PubMed ID: 18295791
[TBL] [Abstract][Full Text] [Related]
5. Cleavage of the transferrin receptor is influenced by the composition of the O-linked carbohydrate at position 104.
Rutledge EA; Enns CA
J Cell Physiol; 1996 Aug; 168(2):284-93. PubMed ID: 8707864
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of murine neutrophil serine proteinases by human and murine secretory leukocyte protease inhibitor.
Wright CD; Kennedy JA; Zitnik RJ; Kashem MA
Biochem Biophys Res Commun; 1999 Jan; 254(3):614-7. PubMed ID: 9920787
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil elastase, proteinase 3 and cathepsin G: physicochemical properties, activity and physiopathological functions.
Korkmaz B; Moreau T; Gauthier F
Biochimie; 2008 Feb; 90(2):227-42. PubMed ID: 18021746
[TBL] [Abstract][Full Text] [Related]
8. Binding pockets on the surface of human leukocyte elastase and human leukocyte cathepsin G. Implications to the design of inhibitors derived from human C-reactive protein.
Yavin EJ; Eisenstein M; Fridkin M
Biomed Pept Proteins Nucleic Acids; 1996-1997; 2(3):71-8. PubMed ID: 9575343
[TBL] [Abstract][Full Text] [Related]
9. Human leukocyte elastase and cathepsin G are specific inhibitors of C5a-dependent neutrophil enzyme release and chemotaxis.
Tralau T; Meyer-Hoffert U; Schröder JM; Wiedow O
Exp Dermatol; 2004 May; 13(5):316-25. PubMed ID: 15140022
[TBL] [Abstract][Full Text] [Related]
10. Effect of E. faecalis on the release of serine proteases elastase and cathepsin G, and collagenase-2 (MMP-8) by human polymorphonuclear leukocytes (PMNs).
Reynaud af Geijersstam A; Sorsa T; Stackelberg S; Tervahartiala T; Haapasalo M
Int Endod J; 2005 Sep; 38(9):667-77. PubMed ID: 16104981
[TBL] [Abstract][Full Text] [Related]
11. Zymogen activation specificity and genomic structures of human neutrophil elastase and cathepsin G reveal a new branch of the chymotrypsinogen superfamily of serine proteinases.
Salvesen G; Enghild JJ
Biomed Biochim Acta; 1991; 50(4-6):665-71. PubMed ID: 1801740
[TBL] [Abstract][Full Text] [Related]
12. Human leukocyte elastase and cathepsin G inactivate factor VII by limited proteolysis.
Anderssen T; Halvorsen H; Bajaj SP; Osterud B
Thromb Haemost; 1993 Sep; 70(3):414-7. PubMed ID: 8259540
[TBL] [Abstract][Full Text] [Related]
13. Biosynthetic profiles of neutrophil serine proteases in a human bone marrow-derived cellular myeloid differentiation model.
Garwicz D; Lennartsson A; Jacobsen SE; Gullberg U; Lindmark A
Haematologica; 2005 Jan; 90(1):38-44. PubMed ID: 15642667
[TBL] [Abstract][Full Text] [Related]
14. Proteases produced by activated neutrophils are able to release soluble CD23 fragments endowed with proinflammatory effects.
Brignone C; Munoz O; Batoz M; Rouquette-Jazdanian A; Cousin JL
FASEB J; 2001 Sep; 15(11):2027-9. PubMed ID: 11511513
[TBL] [Abstract][Full Text] [Related]
15. Cathepsin G in human mononuclear phagocytes: comparisons between monocytes and U937 monocyte-like cells.
Senior RM; Campbell EJ
J Immunol; 1984 May; 132(5):2547-51. PubMed ID: 6562154
[TBL] [Abstract][Full Text] [Related]
16. Modulation of tissue factor and tissue factor pathway inhibitor-1 by neutrophil proteases.
Steppich BA; Seitz I; Busch G; Stein A; Ott I
Thromb Haemost; 2008 Dec; 100(6):1068-75. PubMed ID: 19132232
[TBL] [Abstract][Full Text] [Related]
17. N-terminal proteolytic processing by cathepsin G converts RANTES/CCL5 and related analogs into a truncated 4-68 variant.
Lim JK; Lu W; Hartley O; DeVico AL
J Leukoc Biol; 2006 Dec; 80(6):1395-404. PubMed ID: 16963625
[TBL] [Abstract][Full Text] [Related]
18. In vivo inhibition of serine protease processing requires a high fractional inhibition of cathepsin C.
Méthot N; Guay D; Rubin J; Ethier D; Ortega K; Wong S; Normandin D; Beaulieu C; Reddy TJ; Riendeau D; Percival MD
Mol Pharmacol; 2008 Jun; 73(6):1857-65. PubMed ID: 18326050
[TBL] [Abstract][Full Text] [Related]
19. Using a Caesalpinia echinata Lam. protease inhibitor as a tool for studying the roles of neutrophil elastase, cathepsin G and proteinase 3 in pulmonary edema.
Cruz-Silva I; Neuhof C; Gozzo AJ; Nunes VA; Hirata IY; Sampaio MU; Figueiredo-Ribeiro Rde C; Neuhof H; Araújo Mda S
Phytochemistry; 2013 Dec; 96():235-43. PubMed ID: 24140156
[TBL] [Abstract][Full Text] [Related]
20. Cleavage of the transferrin receptor by human granulocytes: differential proteolysis of the exosome-bound TFR.
Johnstone RM
J Cell Physiol; 1996 Aug; 168(2):333-45. PubMed ID: 8707869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
